AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PULSE BIOSCIENCES, INC. Director's Dealing 2023

Aug 29, 2023

32093_dirs_2023-08-28_76b1a276-4220-4651-889c-94d7efc2a62a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2023-08-25

Reporting Person: DUGGAN ROBERT W (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-08-25	Common Stock	M	1667	$5.95	Acquired	36233291	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-08-25	Stock Option (right to buy)	$5.95	M	1667	Disposed	2033-05-25	Common Stock (1667)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	492069	Indirect

Footnotes

F1: Shares are held by Genius Inc., of which the Reporting Person is the sole shareholder.

F2: Pursuant to the Company's Amended and Restated Outside Director Compensation Policy, this option vests on a monthly basis following the Company's last Annual Stockholder Meeting.